These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19105585)

  • 1. The efficacy and safety of cilomilast in COPD.
    Rennard S; Knobil K; Rabe KF; Morris A; Schachter N; Locantore N; Canonica WG; Zhu Y; Barnhart F
    Drugs; 2008; 68 Suppl 2():3-57. PubMed ID: 19105585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4.
    Rennard SI; Schachter N; Strek M; Rickard K; Amit O
    Chest; 2006 Jan; 129(1):56-66. PubMed ID: 16424413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilomilast.
    Schachter EN
    Drugs Today (Barc); 2006 Apr; 42(4):237-47. PubMed ID: 16703120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of Cilomilast.
    Down G; Siederer S; Lim S; Daley-Yates P
    Clin Pharmacokinet; 2006; 45(3):217-33. PubMed ID: 16509757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update and appraisal of the cilomilast Phase III clinical development programme for chronic obstructive pulmonary disease.
    Giembycz MA
    Br J Clin Pharmacol; 2006 Aug; 62(2):138-52. PubMed ID: 16842388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study.
    Compton CH; Gubb J; Nieman R; Edelson J; Amit O; Bakst A; Ayres JG; Creemers JP; Schultze-Werninghaus G; Brambilla C; Barnes NC;
    Lancet; 2001 Jul; 358(9278):265-70. PubMed ID: 11498212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease.
    Gamble E; Grootendorst DC; Brightling CE; Troy S; Qiu Y; Zhu J; Parker D; Matin D; Majumdar S; Vignola AM; Kroegel C; Morell F; Hansel TT; Rennard SI; Compton C; Amit O; Tat T; Edelson J; Pavord ID; Rabe KF; Barnes NC; Jeffery PK
    Am J Respir Crit Care Med; 2003 Oct; 168(8):976-82. PubMed ID: 12816740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of cilomilast in COPD. Forward.
    Agusti A
    Drugs; 2008; 68 Suppl 2():1-2. PubMed ID: 19105584
    [No Abstract]   [Full Text] [Related]  

  • 9. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.
    Chong J; Leung B; Poole P
    Cochrane Database Syst Rev; 2013 Nov; (11):CD002309. PubMed ID: 24190161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.
    Chong J; Poole P; Leung B; Black PN
    Cochrane Database Syst Rev; 2011 May; (5):CD002309. PubMed ID: 21563134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers.
    Houghton LA; Atkinson W; Whorwell PJ; Morris J; Murdoch RD; Cooper SM; Webber DM; Walls CM
    Clin Ther; 2006 Apr; 28(4):569-81. PubMed ID: 16750468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does a single dose of the phosphodiesterase 4 inhibitor, cilomilast (15 mg), induce bronchodilation in patients with chronic obstructive pulmonary disease?
    Grootendorst DC; Gauw SA; Baan R; Kelly J; Murdoch RD; Sterk PJ; Rabe KF
    Pulm Pharmacol Ther; 2003; 16(2):115-20. PubMed ID: 12670781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
    Ni H; Htet A; Moe S
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cilomilast: a second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease.
    Giembycz MA
    Expert Opin Investig Drugs; 2001 Jul; 10(7):1361-79. PubMed ID: 11772257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies.
    Kerwin EM; Gotfried MH; Lawrence D; Lassen C; Kramer B
    Clin Ther; 2011 Dec; 33(12):1974-84. PubMed ID: 22177371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease.
    Lipworth BJ
    Lancet; 2005 Jan 8-14; 365(9454):167-75. PubMed ID: 15639300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cilomilast (Ariflo) on TNF-alpha, IL-8, and GM-CSF release by airway cells of patients with COPD.
    Profita M; Chiappara G; Mirabella F; Di Giorgi R; Chimenti L; Costanzo G; Riccobono L; Bellia V; Bousquet J; Vignola AM
    Thorax; 2003 Jul; 58(7):573-9. PubMed ID: 12832668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin pharmacodynamics unaffected by cilomilast.
    Kelly J; Murdoch RD; Clark DJ; Webber DM; Fuder H
    Ann Pharmacother; 2001 Dec; 35(12):1535-9. PubMed ID: 11793614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.